Open | $253.980 |
Close | $253.870 |
Volume / Avg. | 734.346K / 1.023M |
Day Range | 252.170 - 254.960 |
52 Wk Range | 167.420 - 261.730 |
Market Cap | $46.208B |
P/E Ratio | 34.665 |
Dividend Yield | - |
Exchange | NYSE |
RSI | 62 |
Short Interest | 2.08% |
Days to Cover | 2.63 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of IQVIA Hldgs (NYSE: IQV) through any online brokerage.
Other companies in IQVIA Hldgs’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Waters (NYSE:WAT) and Danaher (NYSE:DHR).
The latest price target for IQVIA Hldgs (NYSE: IQV) was reported by Truist Securities on Tuesday, February 27, 2024. The analyst firm set a price target for 297.00 expecting IQV to rise to within 12 months (a possible 16.99% upside). 35 analyst firms have reported ratings in the last year.
The stock price for IQVIA Hldgs (NYSE: IQV) is $253.87 last updated March 18, 2024 at 4:00 PM EDT.
There are no upcoming dividends for IQVIA Hldgs.
IQVIA Hldgs’s Q1 earnings are confirmed for Thursday, April 25, 2024.
There is no upcoming split for IQVIA Hldgs.
IQVIA Hldgs is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.